Important regulatory news last week included Otsuka gaining accelerated Food and Drug Administration approval for its Voyxact (sibeprenlimab) for immunoglobulin A nephrology, India’s Sun Pharma for ...

International understanding of China’s arrival as a leading player on the world stage as an innovator of new medicines is now ...

India’s pharmaceutical sector is witnessing global majors deepening their footprint in advanced therapies. The Central Drugs ...

Cantor Fitzgerald issued a note showing that this week saw a broad-based bounce back in GLP-1 prescription activity after ...

US biotech Vanda Pharmaceuticals (Nasdaq: VNDA) says the American medicines regulator has extended its expedited re-review of ...

US drugmaker AbbVie has announced two updates for Canadians living with ulcerative colitis (UC) in relation to its drug ...

China's National Medical Products Administration (NMPA) has approved Innovent Biologics’ Pecondle (picankibart injection), a ...

Swiss incubator Xlife Sciences has provided an update on the ongoing listing process of its portfolio company VERAXA Biotech, ...

Dr Pejvack Motlagh has been appointed as the new chief medical officer of French biopharma Genfit, a French biotech company ...

Zhongmou Therapeutics, a Chinese genomic medicine company focused on restoring vision through gene and optogenetic therapies, ...

The European Association of Hospital Pharmacists (EAHP) released the results of its new Shortages Survey, assessing and ...

Eisai (TYO: 4523) has submitted a new drug application in Japan for a subcutaneous autoinjector version of Leqembi (lecanemab ...